Management of Paroxystic Atrial Fibrillation in French Intensive Care Units
NCT ID: NCT03977883
Last Updated: 2021-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
742 participants
OBSERVATIONAL
2019-05-13
2020-08-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention
NCT06735001
Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
NCT06833138
Long-term Recurrence Rates of Atrial Fibrillation Following New-onset Atrial Fibrillation During ICU Admission
NCT05151523
Analysis of Endocavitary Electrical Signal and Surface Electrocardiogram to Predict Ablation Outcome in Persistent Atrial Fibrillation
NCT03937089
Electrophysiological Effects of NACOS and AVK on Pulmonary Veins and Left Atrium in Paroxysmal AF Catheter Ablation
NCT02814955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The PAF-ICU trial is an observational, prospective, multicenter, transversal trial. The main objective is to evaluate the management of paroxytic atrial fibrillation that occur in ICU.
The investigators want to document 2500 episodes of paroxystic atrial fibrillation in 50 ICU centers. In each center, the episodes are included consecutively until the required 50 episodes are obtained for each center.
A patient can present several episodes and each episode can be included in the study. A new episode is considered as such if it occurs more than one hour after the previous episode.
The follow-up period for each patient corresponds to the ICU stay.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient hospitalized in ICU
* New onset atrial fibrillation
Exclusion Criteria
* Parturient or breast-feeding woman
* Persistent or permanent atrial fibrillation
* Patients after cardiovascular or thoracic surgery
* Patients with therapeutic limitations
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
French Society of Anesthesia and Intensive Care Medecine
UNKNOWN
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Michel Constantin
Role: STUDY_DIRECTOR
Réa Adulte CHU Clermont-Ferrand
Bernard Cosserant
Role: PRINCIPAL_INVESTIGATOR
Neuro-Réa CHU Clermont-Ferrand
Raiko Blondonnet
Role: PRINCIPAL_INVESTIGATOR
RMC CHU Clermont-Ferrand
Eric Kipnis
Role: PRINCIPAL_INVESTIGATOR
CHU Lille
Jonathan Paillot
Role: PRINCIPAL_INVESTIGATOR
CHU Besancçon
Charles Vidal
Role: PRINCIPAL_INVESTIGATOR
CHU de la Réunion
Laurent Muller
Role: PRINCIPAL_INVESTIGATOR
CHU Nimes
Johann Auchabie
Role: PRINCIPAL_INVESTIGATOR
CH Cholet
Guillaume Grillet
Role: PRINCIPAL_INVESTIGATOR
CH Lorient
Philippe Seguin
Role: PRINCIPAL_INVESTIGATOR
CHU Rennes
Philippe Guerci
Role: PRINCIPAL_INVESTIGATOR
CHRU Nancy
Bernard Lalanne
Role: PRINCIPAL_INVESTIGATOR
Hôpital Saint-Joseph - Marseille
Marc Leone
Role: PRINCIPAL_INVESTIGATOR
Hôpital Nord - APHM
Stanislas Ledochowski
Role: PRINCIPAL_INVESTIGATOR
CH Bourgoin-Jallieu
Matthieu Legrand
Role: PRINCIPAL_INVESTIGATOR
Hôpital Saint-Louis - APHP
Jeremy Bourenne
Role: PRINCIPAL_INVESTIGATOR
La Timone APHM
Michel Durand
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Grenoble
Antoine Monsel
Role: PRINCIPAL_INVESTIGATOR
La Pitié Sapêtrière
Mathieu Guilbart
Role: PRINCIPAL_INVESTIGATOR
CHU Amiens
Matthieu Biais
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Cédric Bruel
Role: PRINCIPAL_INVESTIGATOR
CH Saint-Joseph Paris
Antoine Roquilly
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Gaëtan Plantefeve
Role: PRINCIPAL_INVESTIGATOR
CH Argenteuil
Jérôme Morel
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Carole Ichai
Role: PRINCIPAL_INVESTIGATOR
CHU NICE
Adrien Auvet
Role: PRINCIPAL_INVESTIGATOR
CH Dax
Enora Atchade
Role: PRINCIPAL_INVESTIGATOR
Hôpital Bichat
Sigismond Lasocki
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Angers
Pierre-Eric Danin
Role: PRINCIPAL_INVESTIGATOR
Clinique Les Sources Nice
Marc Danguy Des Deserts
Role: PRINCIPAL_INVESTIGATOR
Hôpital d'Instruction des Armées de Brest
Evelina Ochin Salatova
Role: PRINCIPAL_INVESTIGATOR
Hôpital Simone Veil - CH d'Eaubonne
Antoine Rouget
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Armand Mekontso Dessap
Role: PRINCIPAL_INVESTIGATOR
Hôpital Henri Mondor APHP
Justine Perrot
Role: PRINCIPAL_INVESTIGATOR
CHU Dijon
Jibba Amraoui
Role: PRINCIPAL_INVESTIGATOR
Institut Régional du Cancer de Montpellier
Matthias Garot
Role: PRINCIPAL_INVESTIGATOR
CHU Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU
Amiens, , France
CHU
Angers, , France
CH
Argenteuil, , France
CHU
Besançon, , France
CHU
Bordeau, , France
CH
Bourgoin, , France
Hôpital d'Instruction des Armées
Brest, , France
CH
Cholet, , France
CHU
Clermont-Ferrand, , France
CH
Dax, , France
CHU
Dijon, , France
CH
Eaubonne, , France
CHU
Grenoble, , France
CHU
Lille, , France
Hôpital du Scorff
Lorient, , France
APHM
Marseille, , France
Hôpital Saint-Joseph
Marseille, , France
La Timone APHM
Marseille, , France
Institut Régional du Cancer de Montpellier
Montpellier, , France
CHU
Nancy, , France
CHU
Nantes, , France
CHU
Nice, , France
Clinique médicale les Sources
Nice, , France
CHU
Nîmes, , France
Groupe Hospitalier Saint Joseph
Paris, , France
Hôpital Bichat
Paris, , France
Hôpital Henri Mondor
Paris, , France
Hôpital La Pitié Salpêtrière
Paris, , France
Hôpital Saint-Louis
Paris, , France
CHU
Rennes, , France
CHU
Saint-Etienne, , France
CHU
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pardo E, Futier E, Muller L, Besch G, Vardon-Bounes F, Kipnis E, Lasocki S, Ledochowski S, Ochin E, Bourenne J, Grillet G, Auvet A, Mekontso Dessap A, Bruel C, Launey Y, Fiorillo M, Jabaudon M, Godet T, Mulliez A, Constantin JM; SFAR Research Network. Management of new-onset atrial fibrillation in critically ill patients: A national multicenter prospective cohort. Anaesth Crit Care Pain Med. 2025 Sep 26;45(1):101617. doi: 10.1016/j.accpm.2025.101617. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAF-ICU - RNI 2018 CONSTANTIN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.